IOL CHEMICALS & PHARM. | SYNCOM HEALTHCARE | IOL CHEMICALS & PHARM./ SYNCOM HEALTHCARE |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.8 | -3.6 | - | View Chart |
P/BV | x | 1.6 | - | - | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. SYNCOM HEALTHCARE |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
SYNCOM HEALTHCARE Mar-20 |
IOL CHEMICALS & PHARM./ SYNCOM HEALTHCARE |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 2 | 22,838.3% | |
Low | Rs | 272 | 1 | 38,885.7% | |
Sales per share (Unadj.) | Rs | 377.6 | 5.0 | 7,565.2% | |
Earnings per share (Unadj.) | Rs | 23.7 | -2.9 | -808.9% | |
Cash flow per share (Unadj.) | Rs | 31.6 | -2.4 | -1,339.1% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | -3.1 | -8,274.1% | |
Shares outstanding (eoy) | m | 58.71 | 40.00 | 146.8% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 0.3 | 350.6% | |
Avg P/E ratio | x | 17.1 | -0.5 | -3,278.3% | |
P/CF ratio (eoy) | x | 12.8 | -0.6 | -1,980.4% | |
Price / Book Value ratio | x | 1.6 | -0.5 | -320.5% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 61 | 38,923.7% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 50 | 3,362.2% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 200 | 11,103.9% | |
Other income | Rs m | 256 | 3 | 9,850.0% | |
Total revenues | Rs m | 22,427 | 202 | 11,087.8% | |
Gross profit | Rs m | 2,257 | -94 | -2,401.3% | |
Depreciation | Rs m | 462 | 23 | 2,014.8% | |
Interest | Rs m | 165 | 3 | 5,699.0% | |
Profit before tax | Rs m | 1,887 | -117 | -1,609.8% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 0 | - | |
Profit after tax | Rs m | 1,391 | -117 | -1,187.3% | |
Gross profit margin | % | 10.2 | -47.1 | -21.6% | |
Effective tax rate | % | 26.2 | 0 | - | |
Net profit margin | % | 6.3 | -58.7 | -10.7% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 47 | 20,588.9% | |
Current liabilities | Rs m | 5,025 | 182 | 2,758.8% | |
Net working cap to sales | % | 20.9 | -67.7 | -30.9% | |
Current ratio | x | 1.9 | 0.3 | 746.3% | |
Inventory Days | Days | 43 | 32 | 134.7% | |
Debtors Days | Days | 8 | 46 | 18.2% | |
Net fixed assets | Rs m | 11,017 | 131 | 8,391.0% | |
Share capital | Rs m | 587 | 400 | 146.8% | |
"Free" reserves | Rs m | 14,490 | -524 | -2,764.5% | |
Net worth | Rs m | 15,077 | -124 | -12,144.3% | |
Long term debt | Rs m | 0 | 117 | 0.0% | |
Total assets | Rs m | 20,684 | 178 | 11,603.9% | |
Interest coverage | x | 12.5 | -39.6 | -31.5% | |
Debt to equity ratio | x | 0 | -0.9 | -0.0% | |
Sales to assets ratio | x | 1.1 | 1.1 | 95.7% | |
Return on assets | % | 7.5 | -64.1 | -11.7% | |
Return on equity | % | 9.2 | 94.4 | 9.8% | |
Return on capital | % | 13.6 | 1,591.9 | 0.9% | |
Exports to sales | % | 26.7 | 0.5 | 5,121.9% | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | 1 | 570,201.9% | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 1 | 570,201.9% | |
Fx outflow | Rs m | 6,052 | 0 | - | |
Net fx | Rs m | -122 | 1 | -11,701.9% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | -1 | -140,540.2% | |
From Investments | Rs m | -1,200 | 6 | -21,428.6% | |
From Financial Activity | Rs m | -41 | -3 | 1,422.1% | |
Net Cashflow | Rs m | -18 | 2 | -1,000.0% |
Indian Promoters | % | 48.2 | 0.1 | 37,069.2% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.0 | - | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 99.9 | 51.9% | |
Shareholders | 130,003 | 29,298 | 443.7% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | SYNCOM HEALTHCARE | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.22% | -0.72% | 0.17% |
1-Month | 6.47% | 17.71% | 1.27% |
1-Year | -0.36% | 36.88% | 54.14% |
3-Year CAGR | -12.69% | 0.00% | 14.74% |
5-Year CAGR | 16.53% | -11.36% | 19.37% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the SYNCOM HEALTHCARE share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of SYNCOM HEALTHCARE the stake stands at 0.1%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of SYNCOM HEALTHCARE.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
SYNCOM HEALTHCARE paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of SYNCOM HEALTHCARE.
For a sector overview, read our pharmaceuticals sector report.
Indian share markets continued the momentum as the session progressed and ended the higher.